Inspire Investing LLC decreased its position in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 40.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,727 shares of the company’s stock after selling 5,941 shares during the quarter. Inspire Investing LLC’s holdings in DocuSign were worth $785,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of DOCU. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign in the 3rd quarter valued at about $28,000. Brooklyn Investment Group acquired a new stake in shares of DocuSign in the 3rd quarter valued at about $33,000. Modus Advisors LLC acquired a new stake in shares of DocuSign in the 4th quarter valued at about $36,000. Reston Wealth Management LLC acquired a new stake in shares of DocuSign in the 3rd quarter valued at about $47,000. Finally, Avior Wealth Management LLC raised its stake in shares of DocuSign by 36.5% in the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after purchasing an additional 145 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.
DocuSign Stock Up 1.2 %
Shares of NASDAQ:DOCU opened at $91.60 on Friday. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The stock has a market cap of $18.51 billion, a PE ratio of 18.89, a P/E/G ratio of 8.30 and a beta of 0.88. The business has a 50 day moving average of $89.51 and a 200-day moving average of $71.17.
Insider Transactions at DocuSign
Analyst Ratings Changes
Several equities analysts have recently weighed in on DOCU shares. JPMorgan Chase & Co. raised their price objective on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Tuesday, December 3rd. UBS Group raised their price objective on DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Robert W. Baird raised their price objective on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Morgan Stanley raised their price objective on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a report on Friday, December 6th. Finally, Wells Fargo & Company raised their price objective on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, DocuSign currently has an average rating of “Hold” and an average target price of $92.45.
View Our Latest Stock Report on DOCU
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- Short Selling – The Pros and Cons
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Why Invest in High-Yield Dividend Stocks?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Investing In Automotive Stocks
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.